PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
08-Jan-2025 STRATEC TO PARTICIPATE IN THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE STRATEC SE
08-Jan-2025 PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference PureTech
08-Jan-2025 uniQure Announces Pricing of its Public Offering uniQure
08-Jan-2025 Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease Tiziana Life Sciences
08-Jan-2025 iTeos to Present at the 43rd Annual J.P. Morgan Healthcare Conference iTeos Therapeutics
08-Jan-2025 "Annotatability" is a New Method to Decode How AI Learns to Label Developed by Hebrew University Researchers Hebrew University of Jerusalem
08-Jan-2025 Formycon and Fresenius Kabi Canada receive Health Canada’s approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Formycon AG
08-Jan-2025 ProBioGen Expands Protein and Viral Manufacturing to Drive Continued Growth ProBioGen
08-Jan-2025 Angelini Ventures co-leads €20 million Series A financing in Neumirna Therapeutics to Develop Next-Generation RNA Therapeutics for Epilepsy and other Neurological Disorders Angelini Ventures
08-Jan-2025 Cambridge Cognition highlights positive CANTAB® results in research by Bristol Myers Squib Cambridge Cognition
08-Jan-2025 Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics Antag Therapeutics
08-Jan-2025 Commit Biologics appoints accomplished R&D executive, Dr Janine Schuurman, to its Board of Directors Commit Biologics
08-Jan-2025 Angelini Ventures co-leads €20 million Series A financing in Neumirna Therapeutics to Develop Next-Generation RNA Therapeutics for Epilepsy and other Neurological Disorders Angelini Ventures
08-Jan-2025 Galapagos to Unlock Shareholder Value by Declaring its Intent to Separate into Two Publicly Traded Entities Galapagos
08-Jan-2025 Galapagos to Present at the 43rd Annual J.P. Morgan Healthcare Conference Galapagos
08-Jan-2025 Medidata Signs Multi-Year Agreement with Bristol Myers Squibb to Extend Relationship and Continue Company’s Use of Platform Medidata
08-Jan-2025 Coulter Partners places seasoned life sciences and CRO leader as CEO of Metrion Biosciences Coulter Partners
08-Jan-2025 StimCell Energetics Inc. Signs Marketing Agreement with Think Ink Marketing AccessWire
08-Jan-2025 tiakis Biotech AG Receives Positive Scientific Advice from the U.S. FDA for Planned Phase II Trial of Tiprelestat tiakis Biotech AG
08-Jan-2025 Jaguar Health Presenting January 13 at Lytham 2025 Investor Healthcare Summit & January 14 at Biotech Showcase AccessWire